Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study

Neurology

Volumn 62, Issue 5, 2004, Pages 714-718

  Otto, M ^a   Cepek, L ^a   Ratzka, P ^a   Doehlinger, S ^a   Boekhoff, I ^b   Wiltfang, J ^c   Irle, E ^a   Pergande, G ^d   Ellers Lenz, B ^e   Windl, O ^g   Kretzschmar, H A ^f   Poser, S ^a   Prange, H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LKH Wehnen   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d Viatris Inc   (Germany)

^e Omega Mediation   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

^g VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; FLUPIRTINE MALEATE; PLACEBO; PRION PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE ASSESSMENT SCALE; APOPTOSIS; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; MALE; MUSCLE WEAKNESS; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; URTICARIA;

EID: 10744219944     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000113764.35026.EF     Document Type: Article

References (18)

1. Otto M, Wiltfang J, Cepek L, et al. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002;58:192-197.
2. Wiltfang J, Esselmann H, Smirnov A, et al. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Ann Neurol 2003;54:263-267.
3. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 1999;353:183-189.
4. Brown P. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology 2002;58:1720-1725.
5. Aguzzi A, Glatzel M, Montrasio F, Prinz M, Heppner FL. Interventional strategies against prion diseases. Nat Rev 2001;2:745-749.
6. Soto C, Saborio GP. Prions: disease propagation and disease therapy by conformational transmission. Trends Mol Med 2001;7:109-114.
7. Dhar S, Bitting RL, Rylova SN, et al. Flupirtine blocks apoptosis in Batten patient lymphoblasts and in human postmitotic CLN3- and CLN2-deficient neurons. Ann Neurol 2002;51:448-466.
8. Müller WE, Romero FJ, Perovic S, Pergande G, Pialoglou P. Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: prevention of amyloid-induced glutathione depletion. J Neurochem 1997;68:2371-2377.
9. Perovic S, Schröder HC, Pergande G, Ushijima H, Muller WE. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126). Exp Neurol 1997;147:518-524.
10. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233.
11. World Health Organization. Consensus on criteria for sporadic CJD, Geneva: World Health Organization, 1998.
12. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-1364.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatrt Res 1975;12:189-198.
14. Kessler J, Denzler P, Markowitsch HJ. Demenz-Test. Weinheim: Beltz-Verlag, 1988.
15. Kretzschmar HA, Ironside JW, DeArmond SJ, Tateishi J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol 1996;53:913-920.
16. Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group. JAMA 1994;271:985-991.
17. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-556.
18. Gassen M, Pergande G, Youdim MB. Antioxidant properties of the triaminopyridine, flupirtine. Biochem Pharmacol 1998;56:1323-1329.